Author:
Cuello Hector A.,Segatori Valeria I.,Alberto Marina,Pesce Analía,Alonso Daniel F.,Gabri Mariano R.
Funder
Cancer National Institute (ARG)
Quilmes National University
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference23 articles.
1. Blackstone EA, Joseph PF. The economics of biosimilars. Am Health Drug Benefits. 2013;6(8):469–78 (Epub 2014/07/06).
2. King S. First word lists: the best selling drugs in 2014. In: First Word Pharma. 2015. http://www.firstwordpharma.com/node/1263906?tsid=17#axzz42Dj7T1GI . Accessed 31 May 2015.
3. Scheinberg MA, Kay J. The advent of biosimilar therapies in rheumatology—”O brave new world”. Nat Rev Rheumatol. 2012;8(7):430–6 (Epub 2012/06/06).
4. Rioufol C, Salles G. Biosimilar monoclonal antibodies in lymphoma: a critical appraisal. Expert Rev Anticancer Ther. 2015;15(5):569–78 (Epub 2015/03/31).
5. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on similar biological medicinal products containing monoclonal antibodies—non-clinical and clinical issues. London: European Medicines Agency; 2012. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific .
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献